Please ensure Javascript is enabled for purposes of website accessibility

Here's What Einhorn's Greenlight Capital Bought and Sold Last Quarter

By Motley Fool Staff - Updated Apr 6, 2017 at 9:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Top holdings and new trades for Greenlight Capital.

At The Motley Fool, we understand that it often pays to zig when Wall Street zags, but that doesn't mean that we don't pay attention to what leading fund managers are buying and selling. And hedge funds, which are rarely in lockstep with the broader market, can be a particularly valuable source of insight.

Every quarter, fund managers overseeing more than $100 million must disclose their quarter-end holdings publicly by filing Securities and Exchange Commission Form 13-F. The form lists all U.S.-traded securities the manager held at the end of the quarter. Although the form doesn't disclose the manager's short positions or the manager's intraquarter trades, it can shine a bright light on his or her long stock bets. To help us make use of 13-F data, we turned to Motley Fool partner AlphaClone, a research and investment-management firm that tracks hedge fund public disclosures and develops investment strategies based on them.

Q4 2010 update
David Einhorn is president of Greenlight Capital. Einhorn started the fund in 1996 and invests primarily in publicly traded North American corporate debt offerings and equities. The firm also manages a fund of funds and a private equity fund through its affiliates. The total market value of Greenlight Capital's disclosed equity holdings as of Dec. 31, 2010 -- the latest period for which data is available -- was $4.8 billion across 38 holdings.  Here's a snapshot of the portfolio's industry allocations.

The fund's 10 largest positions (shares held) and associated changes as of Dec. 31 were:

  1. Ensco (NYSE: ESV) -- No change
  2. Pfizer (NYSE: PFE) -- Reduced 5.0%
  3. CIT Group  (NYSE: CIT) – Reduced 33.9%
  4. CareFusion (NYSE: CFN) -- Reduced 4.8%
  5. Apple  (Nasdaq: AAPL) -- No change
  6. Cardinal Health (NYSE: CAH) -- Reduced  3.7%
  7. Sprint (NYSE: S) -- New
  8. Market Vectors Gold Miners (NYSE: GDX) -- Increased 37.3%
  9. Microsoft -- Increased 0.3%
  10. NCR  (NYSE: NCR) -- No change

During the quarter, besides the top holdings, the fund has increased its positions in several other holdings. Some highlights include Ingram Micro and Becton, Dickinson. On the sell side, the fund reduced its exposure in Health Net and Verigy. The fund also sold out of three stocks: Ralcorp Holdings, Foster Wheeler, and Oritani Financial.

Following Greenlight Capital
Is it worth paying attention to Einhorn's moves? According to AlphaClone's back-test simulation, anyone who invested in Greenlight Capital’s 10 largest holdings at the time they were disclosed publicly each quarter would have returned 232.0% since 2000, versus 10.5% for the S&P 500 (including dividends) as of March 28. Here’s a chart showing AlphaClone’s back-test model:

The strategy above buys/sells its holdings each quarter, five trading days after the SEC's filing window for Form 13-F closes.

Selected Q4 2010 commentary
Greenlight Capital has a diversified portfolio. Financial, technology, and health care are the three biggest sectors, representing 22.0%, 20.7%, and 19.9% of the portfolio, respectively. Here’s where the firm is winning and where it's making new bets:

Current winner
Ensco was a big winner to close out 2010, rising 20% in the fourth quarter of the last year. The stock comprises 10% of the total portfolio. Enesco is engaged in the drilling of offshore oil and natural gas wells by providing its drilling rigs and crews under contracts with major international, government-owned, and independent oil and gas companies. The company reported revenue of $1.7 billion in 2010 and has a TTM price-to-earnings ratio of 14. The stock has a five-star (out of 5) rating at Motley Fool CAPS.

New bets
The largest new addition, Sprint, comprises almost 5% of the total portfolio. The company is the third-largest U.S. wireless carrier and has a market capitalization of $13.7 billion. Sprint has a two-star rating in Motley Fool CAPS.

During the quarter, the fund also started new positions in BP, PotashCorp, Lyondellbasell Industries, SemGroup, and Capitol Federal.

So there you have it, the blow by blow of Greenlight Capital’s latest moves and why it can matter to your portfolio.  Tell us what you think in the comments below. 

Company data provide by AlphaClone LLC, a San Francisco-based research and investment management firm that tracks hedge fund public disclosures. For more information on the firm's investment approach, click here to visit AlphaClone.

IMPORTANT DISCLOSURES FOR BACKTEST PERFORMANCE RESULTS

Back-testing is the process of evaluating a core strategy by applying it to historical data. Back-tested performance results are provided for purposes of illustrating historical performance had a core strategy had been available during the relevant period. Back-tested performance results are hypothetical and have inherent limitations. AlphaClone makes no representation that any core strategy will achieve performance similar to any back-tested performance results. Actual results could differ materially from back-tested performance and future results could differ materially from back-tested performance. Past performance is no indication or guarantee of future results.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Apple Inc. Stock Quote
Apple Inc.
AAPL
$138.93 (1.62%) $2.21
Sprint Corporation Stock Quote
Sprint Corporation
S
Pfizer Inc. Stock Quote
Pfizer Inc.
PFE
$52.31 (-0.23%) $0.12
Cardinal Health, Inc. Stock Quote
Cardinal Health, Inc.
CAH
$53.10 (1.59%) $0.83
Valaris plc Stock Quote
Valaris plc
VAL
NCR Corporation Stock Quote
NCR Corporation
NCR
$30.38 (-2.35%) $0.73
VanEck Vectors ETF Trust - VanEck Vectors Gold Miners ETF Stock Quote
VanEck Vectors ETF Trust - VanEck Vectors Gold Miners ETF
GDX
$28.16 (2.85%) $0.78
CIT Group Inc. Stock Quote
CIT Group Inc.
CIT

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.